Definium Therapeutics Inc. Common Shares vs Ovintiv Inc. (DE) — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Ovintiv Inc. (DE) trades at $62.88 (market cap $16.99B). The key difference: Ovintiv Inc. (DE) is far larger — about 3.6× Definium Therapeutics Inc. Common Shares's market cap, and Ovintiv Inc. (DE) pays a 1.95% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Ovintiv Inc. (DE) for 0 Days on average.
| DFTX | OVV | |
|---|---|---|
Market Cap | $4.71B | $16.99B |
Volume | 1,966,636 | 3,019,678 |
Sector | Health | Energy |
52-Week High | $48.45 | $66.97 |
52-Week Low | $10.68 | $35.97 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.67B | $21.32B |
Dividend Yield | — | 1.95% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Ovintiv explores for and produces oil and natural gas in North America. Its operations are concentrated in major U.S. and Canadian resource basins.
Read more on OVV →